Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07385131Recruiting

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

Role: collaborator

NCT07088757Phase 4Recruiting

Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis

Role: collaborator

NCT04694248Not ApplicableRecruiting

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT06939387Recruiting

Drug-induced Kidney Injury Model

Role: collaborator

NCT06481410Not ApplicableRecruiting

Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock

Role: collaborator

NCT04813705Phase 2Recruiting

18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

Role: collaborator

NCT04915001Completed

An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province

Role: collaborator

NCT04915690Unknown

Investigation on the Practice Status of Emergency Stuff

Role: collaborator

NCT02741414Not ApplicableUnknown

A Multi-center Study for Eradication of Refractory Helicobacter Pylori

Role: collaborator

All 10 trials loaded